Deltanoid Pharmaceuticals Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Deltanoid Pharmaceuticals General Information

Description

Developer of biopharmaceutical drugs designed to improve human health. The company is focused on unlocking the power of the vitamin D receptor (VDR) and developing therapies derived from vitamin D-based compounds, enabling doctors to transform health outcomes for patients with diseases of the kidney, bone, and skin.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1603 Monroe Street
  • Madison, WI 53711
  • United States
+1 (608)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 1603 Monroe Street
  • Madison, WI 53711
  • United States
+1 (608)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deltanoid Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Mar-2019 Completed Out of Business
2. Later Stage VC (Series B) 15-Jan-2008 Completed Startup
1. Early Stage VC (Series A) 04-Jun-2001 $4.25M $4.25M Completed Startup
To view Deltanoid Pharmaceuticals’s complete valuation and funding history, request access »

Deltanoid Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Deltanoid Pharmaceuticals’s complete cap table history, request access »

Deltanoid Pharmaceuticals Patents

Deltanoid Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1694333-A2 Methods for reducing body fat using vitamin d compounds Inactive 25-Nov-2003
WO-2005051396-A2 Methods for reducing body fat using vitamin d compounds Inactive 25-Nov-2003
WO-2005051396-A3 Methods for reducing body fat using vitamin d compounds Inactive 25-Nov-2003 A61K31/59

Deltanoid Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deltanoid Pharmaceuticals FAQs

  • When was Deltanoid Pharmaceuticals founded?

    Deltanoid Pharmaceuticals was founded in 1999.

  • Where is Deltanoid Pharmaceuticals headquartered?

    Deltanoid Pharmaceuticals is headquartered in Madison, WI.

  • What is the size of Deltanoid Pharmaceuticals?

    Deltanoid Pharmaceuticals has 2 total employees.

  • What industry is Deltanoid Pharmaceuticals in?

    Deltanoid Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Deltanoid Pharmaceuticals a private or public company?

    Deltanoid Pharmaceuticals is a Private company.

  • What is Deltanoid Pharmaceuticals’s current revenue?

    The current revenue for Deltanoid Pharmaceuticals is .

  • How much funding has Deltanoid Pharmaceuticals raised over time?

    Deltanoid Pharmaceuticals has raised $16.3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process